CC
Live chart
What they do
The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. The company operates through three segments: Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials. The Thermal & Specialized Solutions segment provides refrigerants, thermal management solutions, propellants, foam blowing agents.
For information only · Important disclosures
Grades vs sector
Momentum34th percentile in sectorC-
Percentile within its GICS sector across the S&P 1500.
Growth12th percentile in sectorD-
Percentile within its GICS sector across the S&P 1500.
Value73rd percentile in sectorB+
Percentile within its GICS sector across the S&P 1500.
Profitability5th percentile in sectorF
Percentile within its GICS sector across the S&P 1500.
RevisionsNot enough data yet–
30-day change in analysts' current-year EPS estimate; graded across covered stocks.
Systematic Models
Not held by any of our 5 live models right now.
News
More newsKey stats
Valuation and fundamentals
Valuation & fundamentals
Discounted cash flow
Starting cash flow is mid-cycle: 3.4% average margin × current revenue = 0.2B (last 12 months: 0.2B at a 4% margin). On trailing cash flow the base case would be $-9.
Edit assumptions · recalculates instantly
Free cash flow = operating cash flow − capital spending, trailing 12 months (TTM to 2026-06-30). Growth default: average of 3-year revenue CAGR and latest revenue growth, capped at 30%. Years 6–10 fade linearly to terminal growth. Discount rate = 4.25% risk-free assumption + beta 1.40 × 5% equity premium, kept within 7–13%. Bear: lower growth, +1 pt discount, 2% terminal. Bull: higher growth, −1 pt, 3%.
Multiples vs Materials
cheaper
cheaper
cheaper
Forward EPS $1.86 vs trailing $-2.03. Forward P/E uses analysts' next-12-month estimate.
Backlog (remaining performance obligations)
Contracted revenue not yet recognized, from SEC filings (XBRL tag RevenueRemainingPerformanceObligation).
Quality & financial health
Piotroski F-score 5/9 · last two fiscal years
Analysts
Annual history
| FY | Revenue | Net income | Free cash flow |
|---|---|---|---|
| 2025 | $5.8B | $-386.0M | $51.0M |
| 2024 | $5.8B | $69.0M | $-993.0M |
| 2023 | $6.1B | $-253.0M | $186.0M |
| 2022 | $6.8B | $578.0M | $448.0M |
| 2021 | $6.3B | $608.0M | $537.0M |
| 2020 | $5.0B | $219.0M | $540.0M |
From the company's 10-K filings via SEC XBRL. 3-year revenue CAGR -5.3%.
Earnings
| Report | EPS est | Actual | Surprise |
|---|---|---|---|
| 2026-08-04 | 0.42 | 0.42 | +0.1% |
| 2026-05-05 | -0.04 | 0.05 | +223.8% |
| 2026-02-19 | 0.02 | 0.05 | +192.1% |
| 2025-11-06 | 0.24 | 0.20 | -17.2% |
| 2025-08-05 | 0.46 | 0.58 | +26.9% |
| 2025-05-06 | 0.20 | 0.13 | -34.5% |
| 2025-02-18 | 0.16 | 0.11 | -29.4% |
| 2024-11-04 | 0.28 | 0.40 | +41.1% |
Quarterly revenue
| Quarter | Revenue | YoY |
|---|---|---|
| 2026-06-30 | $1.6B | -1.5% |
| 2026-03-31 | $1.4B | – |
| 2025-12-31 | $1.3B | – |
| 2025-09-30 | $1.5B | – |
| 2025-06-30 | $1.6B | – |
Rating changes
Third-party analyst actions, not Coteau's views. All rating changes
Recent dividends
Insider trades
$30.1K
$50.5K
$95.0K
$30.0K
$30.0K
$203.1K
$50.0K
–
–
–
–
–
Stats refreshed 2026-10-22 21:10:52 ET from Yahoo Finance (yfinance). "–" means the data isn't available. Refresh now
Independent research · Not investment advice · Hypothetical unless marked Live · Data: Yahoo Finance (15-min delayed), SEC EDGAR, House Clerk · Important disclosures · Contact desk@coteau.app
Beta 0.9 · Oct 21, 2026